- 2016 – ISMRD and its partners fund Gene Therapy Research in Mucolipdisois
- 2016 – ISMRD and its partners fund Osteoporosis in Mucolipidosis II – A Potential Corrective approach.
- 2013 – ISMRD partners with the US MPS Society to support Research Investigating the role of Catyhespin Proteases in MLII Cardiac Pathology. Investigator: Heather Flanagan-Steet.